| COVID-19 pandemic, coronaviruses, and diabetes mellitus R Muniyappa, S Gubbi American Journal of Physiology-Endocrinology and Metabolism, 2020 | 1065 | 2020 |
| Benefits of metformin in attenuating the hallmarks of aging AS Kulkarni, S Gubbi, N Barzilai Cell metabolism 32 (1), 15-30, 2020 | 483 | 2020 |
| Metabolic syndrome and COVID 19: endocrine-immune-vascular interactions shapes clinical course R Bansal, S Gubbi, R Muniyappa Endocrinology 161 (10), bqaa112, 2020 | 119 | 2020 |
| Updates on the management of thyroid cancer KA Araque, S Gubbi, J Klubo-Gwiezdzinska Hormone and Metabolic Research 52 (08), 562-577, 2020 | 118 | 2020 |
| 40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain S Gubbi, GF Quipildor, N Barzilai, DM Huffman, S Milman Journal of molecular endocrinology 61 (1), T171-T185, 2018 | 93 | 2018 |
| Hypophysitis: an update on the novel forms, diagnosis and management of disorders of pituitary inflammation S Gubbi, F Hannah-Shmouni, JG Verbalis, CA Koch Best Practice & Research Clinical Endocrinology & Metabolism 33 (6), 101371, 2019 | 78 | 2019 |
| Novel targeted therapies for metastatic thyroid cancer—a comprehensive review M Al-Jundi, S Thakur, S Gubbi, J Klubo-Gwiezdzinska Cancers 12 (8), 2104, 2020 | 66 | 2020 |
| Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice GE Farias Quipildor, K Mao, Z Hu, A Novaj, MH Cui, M Gulinello, ... Geroscience 41, 185-208, 2019 | 66 | 2019 |
| Catecholamine physiology and its implications in patients with COVID-19 S Gubbi, MA Nazari, D Taieb, J Klubo-Gwiezdzinska, K Pacak The Lancet Diabetes & Endocrinology 8 (12), 978-986, 2020 | 59 | 2020 |
| COVID-19 and chronic fatigue syndrome: An endocrine perspective R Bansal, S Gubbi, CA Koch Journal of Clinical & Translational Endocrinology 27, 100284, 2022 | 56 | 2022 |
| Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions S Gubbi, F Hannah-Shmouni, CA Stratakis, CA Koch Reviews in Endocrine and Metabolic Disorders 19, 335-347, 2018 | 53 | 2018 |
| A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin JN Justice, S Gubbi, AS Kulkarni, JM Bartley, GA Kuchel, N Barzilai Geroscience 43, 1093-1112, 2021 | 41 | 2021 |
| Artificial intelligence and machine learning in endocrinology and metabolism: the dawn of a new era S Gubbi, P Hamet, J Tremblay, CA Koch, F Hannah-Shmouni Frontiers in endocrinology 10, 185, 2019 | 41 | 2019 |
| Diagnostic testing for diabetes insipidus S Gubbi, F Hannah-Shmouni, CA Koch, JG Verbalis | 39 | 2019 |
| Climate change and obesity CA Koch, P Sharda, J Patel, S Gubbi, R Bansal, MJ Bartel Hormone and Metabolic Research 53 (09), 575-587, 2021 | 35 | 2021 |
| Effect of exceptional parental longevity and lifestyle factors on prevalence of cardiovascular disease in offspring S Gubbi, E Schwartz, J Crandall, J Verghese, R Holtzer, G Atzmon, ... The American journal of cardiology 120 (12), 2170-2175, 2017 | 29 | 2017 |
| Management of mitochondrial diabetes in the era of novel therapies RO Yeung, M Al Jundi, S Gubbi, ME Bompu, S Sirrs, M Tarnopolsky, ... Journal of Diabetes and its Complications 35 (1), 107584, 2021 | 27 | 2021 |
| Hypertension and COVID-19: Updates from the era of vaccines and variants S Swamy, CA Koch, F Hannah-Shmouni, EL Schiffrin, ... Journal of clinical & translational endocrinology 27, 100285, 2022 | 22 | 2022 |
| Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation Z Abdul Sater, A Jha, A Hamimi, A Mandl, IR Hartley, S Gubbi, M Patel, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), 1176-1185, 2020 | 22 | 2020 |
| Peptide receptor radionuclide therapy in thyroid cancer S Gubbi, CA Koch, J Klubo-Gwiezdzinska Frontiers in endocrinology 13, 896287, 2022 | 16 | 2022 |
Fady Hannah-Shmouni, MD, DABIM, A...Adult Endocrinology, Biochemical Genetics and HypertensionVerified email at nih.gov
